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Background: Knowing and, if necessary, altering competitive athletes’ real attitudes towards the use of banned
performance-enhancing substances is an important goal of worldwide doping prevention efforts. However athletes
will not always be willing to reporting their real opinions. Reaction time-based attitude tests help conceal the
ultimate goal of measurement from the participant and impede strategic answering. This study investigated how
well a reaction time-based attitude test discriminated between athletes who were doping and those who were not.
We investigated whether athletes whose urine samples were positive for at least one banned substance (dopers)
evaluated doping more favorably than clean athletes (non-dopers).
Methods: We approached a group of 61 male competitive bodybuilders and collected urine samples for biochemical
testing. The pictorial doping Brief Implicit Association Test (BIAT) was used for attitude measurement. This test
quantifies the difference in response latencies (in milliseconds) to stimuli representing related concepts (i.e. doping–
dislike/like–[health food]).
Results: Prohibited substances were found in 43% of all tested urine samples. Dopers had more lenient attitudes to
doping than non-dopers (Hedges’s g = −0.76). D-scores greater than −0.57 (CI95 = −0.72 to −0.46) might be indicative
of a rather lenient attitude to doping. In urine samples evidence of administration of combinations of substances,
complementary administration of substances to treat side effects and use of stimulants to promote loss of body fat was
common.
Conclusion: This study demonstrates that athletes’ attitudes to doping can be assessed indirectly with a reaction time-
based test, and that their attitudes are related to their behavior. Although bodybuilders may be more willing to reveal
their attitude to doping than other athletes, these results still provide evidence that the pictorial doping BIAT may be
useful in athletes from other sports, perhaps as a complementary measure in evaluations of the effectiveness of doping
prevention interventions.
Keywords: Steroid use, Psychology, Doping tests, Biochemical profilesBackground
Doping is defined as the presence of a prohibited sub-
stance or its metabolites or markers (including elevated
quantities of endogenous substances), or evidence of use
of a prohibited method, in an athlete’s sample. Although
only 1.19% of the 267,645 samples analyzed and reported
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unless otherwise stated.laboratories in the year 2012 produced adverse analytical
findings [1], the percentage of doping cases which remain
unrevealed is thought to be considerably higher. For ex-
ample, recent analyses of biochemical data from 2,737
elite track and field athletes exposed evidence of blood
doping in an average of 14% of athletes, with prevalence
varying considerably across nationalities (between 1% and
48% in range) [2].
There is strong evidence that attitudes can be used to
predict behavior [3]. Several studies have already re-
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admitted doping. For example, a study reported that atti-
tude to doping was a significant predictor of doping
intention in a sample of 1,075 Greek elite athletes [4].
Another study of a sample of 729 athletes reported that
attitudes to doping helped to explain participants’ will-
ingness to dope [5]. Another study used data from 750
elite athletes to demonstrate that sportspersonship ori-
entations and achievement goals exerted an indirect in-
fluence on doping intentions through their influence on
attitudes to doping and self-efficacy beliefs [6]. A recent
meta-analysis concluded that attitudes to doping are
amongst the strongest predictors of self-admitted doping
behavior [7].
Extant psychological studies on doping behavior rely
almost exclusively on verbal self-reports of attitudes to
doping and use of doping. Unfortunately direct self-
report instruments, for example questionnaires on
doping-related cognition or use of doping, are prone to
a social desirability bias [8]. Athletes will not always re-
port their attitude or behavior frankly, they may start to
deliberate and give what they believe to be the socially
desirable response [9].
The Implicit Association Test (IAT) is a reaction time-
based method which helps to address the problem of
strategic answering in such situations [10-12]. There is
ample evidence that IAT effects can be interpreted as in-
dicators of attitudes [13].
The IAT is based on the theoretical assumption that
knowledge is stored in our memory in an association
network. Information is stored as nodes in an associative
network of semantic information. If a node is activated
the activation spreads through the network and associated
nodes are automatically activated [14]. Activation of a
doping-related semantic concept, for example by present-
ing the words Erythropoietin or EPO (a drug which can be
used as a doping substance), should automatically activate
the associated evaluation (e.g. positive or negative).
The test is typically presented on a computer in the
form of a lexical sorting task in which two concepts (one
target and one evaluative) are mapped to the same com-
puter key. The sorting task is easier for the respondent
(and therefore completed more quickly) when the two
concepts sharing the same response key are closely asso-
ciated than when they are not (e.g. an athlete who disap-
proves of doping will respond more quickly when doping
and dislike are mapped to the same key than when dop-
ing and like are mapped to the same key). IAT scores are
calculated by using the difference between response
times for related and unrelated pairs. Response times are
interpreted as a measure of the associative strength be-
tween the target concept and the attribute.
To date relatively little research has directly addressed
the associative and automatic nature of the processunderlying the IAT effect [13]. Non-associative, e.g.
propositional accounts therefore remain viable alterna-
tive interpretations of IAT effects [15,16] although at
present it seems unreasonable to reject the assumption
of an underlying associative process [17]. The IAT is
currently the method of choice for testing automatic as-
sociations, as it incorporates core features of implicit
psychological measurement [18].
Petróczi, Aidman and Nepusz reported seminal work
on use of IATs for measuring attitudes to doping [19].
They showed that subjects responded faster to pairings
of doping with bad than to pairings of doping with good.
Brand, Melzer and Hagemann [20] compared the meas-
urement properties of this early version of a doping IAT
[19] with an alternative procedure [21] and showed that
test results were strongly dependent on the test stimuli
used. Shortly thereafter Petróczi et al. [22] published
preliminary results from a study in which a brief IAT
(BIAT) was employed. The BIAT is a shorter version of
the standard IAT procedure [23]. Six athletes who de-
nied current doping in a questionnaire although bio-
chemical traces of banned substances were detected in
their hair samples responded more rapidly to the good-
doping pair than the 4 athletes who admitted doping.
However the difference was very small and the variance
was large so the result was not statistically significant.
The authors elaborated on these preliminary findings in
a later article [24], concluding that self-reported atti-
tudes to doping in a questionnaire aligned well with ad-
mitted use, whereas BIAT results aligned better with
biochemical test results (although differences in re-
sponse latencies did not reach statistical significance).
Their results suggested that an exaggerated divergence
between direct (questionnaire self-report) and indirect
(BIAT) measures of attitude might be characteristic of
deniers, whilst clean athletes would show convergent re-
sponse patterns. There were limitations to these two
studies [22,24], namely that the findings were based on a
sample of only 10 athletes and the method of biochem-
ical testing was suboptimal (e.g. there was no differenti-
ation between endogenous hormones and introduced
substances).
Recently Brand, Heck and Ziegler [25] introduced a
new BIAT for measuring athletes’ attitudes to doping
that uses pictures instead of word stimuli. This test
might thus provide the basis for a transnationally valid
instrument which could be used as part of a harmonized
worldwide anti-doping effort. In their study the new
doping BIAT was found to have adequate psychometric
properties and athletes’ attitudes to doping were shown
to be associated with how prone their discipline was to
doping.
In order to investigate whether this pictorial doping
BIAT [25] successfully discriminates dopers from non-
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of doping is thought to be particularly high: bodybuild-
ing is not subject to WADA regulations, and use of ana-
bolic steroids is seen as an integral part of the culture of
the sport by most bodybuilders [26]. Although compelling
evidence from epidemiological studies is very rare, there
has been at least one previous study in which between 38
and 58% of competitive bodybuilders had positive bio-
chemical test results indicating the use of performance en-
hancing drugs (i.e. doping in most other sports) [27].
This study extends the current knowledge as it tested
the hypothesis that lenient attitudes to doping are linked
with doping behavior. Results of biochemical urine ana-
lyses were used to classify participating bodybuilders as
dopers or non-dopers, and biochemical profiles of doping-
users in bodybuilding are given. The pictorial doping BIAT
[25] was used to measure participants’ attitudes to doping.
We assessed the sensitivity and specificity of the pictorial
doping BIAT as a means of discriminating dopers and
non-dopers, hypothesizing that dopers would have a more
lenient attitude to doping.
Materials and methods
Participants and data collection
On the basis of the result of an a priori power calcula-
tion (n ≥ 52; independent samples t-test; Cohen’s d = 0.7,
α = 0.05 and 1-β = 0.80), we sampled 61 male com-
petitive bodybuilders (M = 30.36 ± 9.29 years old). These
bodybuilders were a convenience sample. All data were
collected between June and October 2013. Two research
assistants recruited bodybuilders personally during train-
ing at their home gyms. They were asked directly if they
would be willing to participate in a confidential research
study which would involve them providing information
about their age, education, training time per week and
competitive experience in a paper-pencil questionnaire
and then working through a computer-based test that
would reveal their attitude to doping and, finally, provid-
ing a doping control urine sample. All biochemical sam-
ples were treated as in-competition doping tests and
analyzed in one of Germany’s WADA-accredited labora-
tories (Institute of Doping Analysis and Sports Biochem-
istry, Dresden) following procedures laid out in the
WADA International Standard for Laboratories [28].
Testing started after participants had provided informed
consent in accordance with the World Medical Associa-
tion’s Declaration of Helsinki (October 2008). Ethical ap-
proval for the study was obtained by the University of
Potsdam on application number 39/2011.
Reaction time-based attitude test
A recent publication provided all the information re-
quired to use the pictorial doping BIAT, including test
specifications and psychometric properties [25]. Thepictorial doping BIAT begins with a training block (20
trials), in which participants learn to discriminate be-
tween the focal doping and the non-focal health food
pictures. After this training block participants perform
one doping-like block (20 trials) and one doping-dislike
block (20 trials). Block presentation order is randomized
across participants to avoid position effects. D-scores are
calculated according to the improved scoring algorithm
[29] such that more positive scores indicate a more leni-
ent attitude to doping. Error rates in this study were
17.8% (SD = 16.9) in the doping-like blocks and 8.9%
(SD = 9.3) in the doping-dislike blocks.
The test was programmed using the Inquisit 3.0™ soft-
ware. It was run on a custom 15.6″ computer notebook
(MS Windows 7; Intel Core i5 2410 M, 2.3 GHz) with a
QWERTZ keyboard.
Biochemical tests
Urine samples were analyzed using mass spectrometry in
combination with either liquid or gas chromatography
and immunoassay was used to detect human chorionic
gonadotropin (hCG). All tests were carried out according
to WADA regulations and technical documents defining
relevant prohibited substances [30], eligible analytical
methodology and identification criteria [31], detection
thresholds [32], decision thresholds, sample processing
and reporting of results [28]. The analytical strategies for
all the prohibited substance classes we investigated,
including testing procedures for detection of anabolic
agents, peptide hormones, stimulants and hormone and
metabolic modulators are described exhaustively in the lit-
erature [33]. Doping substances were classified according
to the WADA 2013 list of prohibited substances [30].
Results
Biochemical tests
Biochemical analyses revealed that 42.6% (26 out of 61)
of the bodybuilders in our sample used at least one
prohibited substance at the time of testing. We found
metabolic modulators, stimulants, cannabinoids (in one
athlete’s sample), the anabolic β2-agonist clenbuterol,
and a broad range of anabolic steroids (Table 1). The
anabolic agents found were testosterone, several conven-
tional synthetic analogues (e.g. drostanolone, trenbolone,
stanozolol) and methasterone (in one athlete’s sample).
This last substance was recently introduced onto the
black market as a designer steroid [34]. Cases of severe
liver damage due to this substance are documented in
the literature [35]. The testosterone-epitestosterone (T/E)
ratio was >10 in 75% of all doping-positive samples (a
ratio >4 is usually taken as an indication of administration
of exogenous testosterone). Carbon isotope ratio mass
spectrometry [36] was used to confirm exogenous origin
where necessary, i.e. in cases where testosterone levels were
Table 1 Prohibited substances in urine samples of bodybuilders (n = number of participants)
S1 S2 S4 S6 S8







Methandienone (n = 5) hCG (n = 1) Tamoxifene (n = 6) Methylhexanamine (n = 2) cTHC (n = 2)
Boldenone (n = 13) Anastrozol (n = 2) Amphetamine (n = 1)
Drostanolone (n = 4) Ephedrine (n = 1)
Methasterone (n = 1) MDMA (n = 1)
Metenolone (n = 1)
Nandrolone (n = 11)
Oxymetholone (n = 1)
Stanozolol (n = 4)
Testosterone (n = 20)
Trenbolone (n = 6)
Clenbuterol (n = 1)
Substances are grouped (S1 to S8) according to the WADA Prohibited List 2013.15 hCG (human chorionic gonadotropin) induces the endogenous biosynthesis of
testosterone, MDMA (3,4-methylenedioxyamphetamine) is the stimulating entactogen marketed as ecstasy, and cTHC (11-nor-9-carboxy-THC) is the urinary marker
of THC-administration.
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positive bodybuilders did not use anabolic agents; nine used
only one anabolic agent; two anabolic substances were
found in four samples; six in three samples; one participant
used four (boldenone, drostanolone, nandrolone, trenbo-
lone), and another six anabolic agents (boldenone, drostano-
lone, metenolone, nandrolone, stanozolol, trenbolone). A
table providing complete biochemical test results for all in-































Figure 1 Results from the doping BIAT attitude measurement. Bars sh
bodybuilders whose urine samples either contained (dopers; n = 26) or did
the WADA prohibited list 2013. Block A refers to the BIAT’s part, in which th
on the same response key (and block B respectively).BIAT and biochemical test results
Bodybuilders whose urine samples contained a prohib-
ited substance (n = 26) did not differ in age, education,
weekly training minutes and years of competitive experi-
ence from those who tested negative (n = 35; all p ≥ .13,
all Hedges’s g ≤ 0.32). Mean BIAT response latencies for
dopers and non-dopers are depicted in Figure 1. The
mean D-score for the group of non-dopers (M = −0.52,







ow mean reaction times (±1 standard deviation) in groups of
not contain (non-dopers; n = 35) forbidden substances according to
e target concept doping and the evaluative concept like are mapped
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p = .002, Hedges’s g = −0.76 (CI95 = 0.24 to 1.29), indicat-
ing that dopers’ reactions were faster than non-dopers’
when the BIAT target concept doping and the evaluative
category like were mapped to the same response key,
which suggests that the two concepts were more closely
associated for dopers than for non-dopers. As a group the
dopers in our sample showed more lenient attitudes to
doping than the non-dopers. Individual D-scores for
all the bodybuilders are included in the table given as
Additional file 1: Table S1.
Results from a subsequent receiver operating character-
istic (ROC) analysis (Figure 2) revealed that BIAT D-scores
could be used to discriminate dopers from non-dopers.
The overall accuracy of the test can be quantified in terms
of the area under the curve (AUC), which in this sample
was .72, indicating that dopers have higher (more positive)
BIAT scores than 72% of the non-dopers. The threshold
BIAT D-score which maximized test sensitivity and speci-
ficity was −0.57 (CI95 = −0.72 to −0.46).
When applied to individual bodybuilders in our sam-
ple (Table 2) this threshold leaves 15.38% of all dopersFigure 2 Results of ROC analysis (receiver operating characteristic). The
dopers from non-dopers. The ROC graph depicts relative tradeoffs between tr
function of each obtained BIAT score. The farther the AUC (Area Under the Cu
chance level (AUC = 0.50), the better the BIAT’s performance is in terms of ma
cut-off score (−0.57), specificity (54.3%) and sensitivity (84.6%) are maximized.undetected (false negatives), and inadvertently classifies
45.71% of clean bodybuilders as dopers (false positives).
The threshold D-score or the upper and lower limits of
the 95% confidence interval might be useful as reference
scores in other studies that use the pictorial doping
BIAT. An illustration of D-score distributions in our
groups of dopers and non-dopers together with the pro-
posed threshold reference scores is given in Figure 3.
Discussion
The pictorial doping BIAT [25] revealed that bodybuilders
whose urine sample contained at least one banned sub-
stance had more lenient attitudes to doping than clean
bodybuilders. This reaction time-based indirect measure
of attitude can be helpful as a complementary indicator of
athletes’ attitudes to doping. Test scores could for example
be used to inform decisions about whether or not athletes
should be recommended for doping prevention interven-
tions. The diagnostic accuracy of the proposed reference
scores is important in the context of potential practical ap-
plications, as is the more general question of whether find-
ings in bodybuilders will generalize to other sports.ROC curve (black) describes the BIAT’s performance in discriminating
ue positives (test sensitivity) and false positives (test specificity) as a
rve = 0.722 ± CI95%) deviates from the diagonal (grey) representing
ximizing true positive and true negative cases. At the proposed BIAT
Table 2 True hits and false alarms (number of participants) produced by the doping BIAT cut-off D-score, proposed to
discriminate test participants (here: bodybuilders) with a rather negative (D ≤ −0.57) or a rather positive (D > −0.57)
doping attitude
BIAT: doping attitude
Rather negative evaluation of doping Rather positive evaluation of doping
Biochemical test: presence of doping
substance in urine sample
Doper 4 22
Non-doper 19 16
Figure 3 Application of proposed reference thresholds on
doping BIAT D-scores. Dots represent all bodybuilders’ (dopers and
non-dopers) individual D-scores. Lower and upper limits of the grey
box represent the range of the 95% confidence interval (−0.72,
−0.46) around the cut-off D-score (horizontal line at −0.57) as
proposed by the ROC analysis.
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a sample of bodybuilding athletes will generalize to other
sports (e.g. Olympic sports such as track and field athlet-
ics, swimming, handball and association football). Unlike
in these other sports, in bodybuilding the use of
performance-enhancing drugs (primarily anabolic ste-
roids) is neither formally nor socially prohibited. It is
therefore possible that bodybuilders have a different atti-
tude and approach to doping and perhaps even report
their thoughts, feelings and behaviors with respect to
doping more honestly [37]. In a very small sample
Petróczi et al. [24] found that dopers could best be dis-
criminated by the dissociation between direct and indir-
ect indicators of attitudes to doping (dopers reported
strong rejection of doping in self-report questionnaires,
but reaction time-based tests indicated a relatively posi-
tive attitude). In our study the indirect test alone was
sufficient to identify dopers. The dissociation pattern
may only be an indicator of doping in sports where dop-
ing is prohibited, which is not the case in bodybuilding.
The results of a previous study were consistent with
this hypothesis, direct and indirect measures of attitude
were positively correlated in bodybuilding but uncorre-
lated in handball [25]. This is the reason why we did not
include a direct measure of attitude in this investigation.
The dissociation hypothesis remains an important re-
search issue and theoretical accounts of the effects
should be developed.
Although bodybuilders may be characterized by more
lenient attitudes to doping than other athletes their
scores on the pictorial BIAT may well be comparable to
those of athletes from other sports. In the only study to
date in which the pictorial doping BIAT was used with
athletes from an Olympic sport [25] 21 bodybuilders at-
titudes to doping were compared with those of 22 hand-
ball players (handball was chosen because it is one of
the sports in which doping is supposed to be less preva-
lent). The average D-score in the bodybuilder group was
−0.14, which is very close to the −0.12 for doped body-
builders in this study (suggesting that the majority of
bodybuilders in the previous study were dopers). The
mean D-score for the handball player group was −0.40,
similar to the −0.52 score for clean bodybuilders in this
study. In our view this corroborates the validity of the
pictorial BIAT as an indirect measure of attitude to
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evidence is needed to confirm this.
Bodybuilders may be less likely to fake a more negative
doping attitude than athletes from other sports. It is im-
portant to note that IAT results can be faked to a certain
degree under specific circumstances [38]. From an eth-
ical point of view it is important to inform participants
that the BIAT is used to assess attitudes to doping be-
fore they take the test, and this is the procedure we
followed in this study. There is currently no evidence on
faking in BIAT tests, but it is sensible to assume that the
pictorial doping BIAT can be faked in a similar fashion
to the IAT. Research addressing the issue of faking is ur-
gently needed, as attempts to fake the test will undoubt-
edly affect its validity and reliability and – not least
important – the applicability of the proposed reference
scores (see discussion below). We can only speculate
about our participants’ high compliancy with testing or
motivation to fake. Regardless of the level of attempted
and successful faking, and more importantly, there is lit-
tle reason to suspect that there are fundamental differ-
ences between bodybuilders and athletes from other
sports in terms of the general processes of attitude forma-
tion and the ways attitudes in which can be assessed. We
therefore propose that the test validation data from this
study should be accepted as a provisional indication that
the pictorial doping BIAT is also valid for athletes from
Olympic sports (i.e. other sports than bodybuilding).
Our statistical analyses suggested that pictorial doping
BIAT D-scores greater than −0.57 were associated with a
rather lenient attitude to doping and that non-dopers are
more likely to have scores below this threshold than
dopers. In our sample this threshold correctly identified
84.6% of dopers; however it also had a high false positive
rate, 45.7% of athletes were mistakenly classified as dopers.
In our view it is reasonable to accept the surplus sensi-
tivity of this threshold. We base our view on the pictor-
ial doping BIAT’s potential as a complementary measure
of and the paramount importance of doping prevention.
We think that it is more important to identify athletes
with comparatively lenient attitudes to doping in order
that they can be recommended for preventative inter-
ventions than to avoid recommending athletes for such
measures when they already have a negative attitude to
doping. It has been argued that inappropriate use of pre-
vention interventions could produce a boomerang effect
[39]. These authors suggested that athletes who have
never previously considered doping, might be prompted
to do so by attending a doping prevention program [40].
We feel that this argument is only valid for athletes who
would have not been faced with doping either way. This
is very unlikely, at least in athletes with a background in
Olympic sport who compete at an advanced level.
Nonetheless researchers or organizations who use thepictorial BIAT e.g. as a complementary measure to
screen for eligibility for doping prevention interventions
should bear in mind that the possibility of a boomerang
effect cannot be ruled out at present.
It is important to note that all groups that have been in-
vestigated with the pictorial doping BIAT so far ([25]; this
study), had a mean score above the proposed threshold
doping BIAT D-score = −0.57. On the one hand this might
indicate that all the groups investigated so far have rela-
tively positive attitudes to doping, but then it might also
be an artifact due to the sensitivity-specificity trade-off dis-
cussed above. In the context of this study it is important
to consider a third explanation for the relatively high D-
scores and a caveat which applies to the interpretation of
absolute D-scores more generally.
Biochemical testing of urine samples provides a rela-
tively short detection window, varying from only several
hours up to a few days depending on factors such as the
substance used, the method and duration of use, sample
storage condition etc. [41]. It is therefore possible that
negative biochemical results in this study were obtained
from dopers who were ‘off-cycle’ at the time of data col-
lection (i.e. taking a break from administration of doping
substances). This means that we cannot rule out the
possibility that bodybuilders with a long history of dop-
ing were assigned to the non-doper group. If this were
the case it might explain the relatively large number of
false positives (see above) and thus strengthen our case
for relying on BIAT scores to indicate likelihood of fu-
ture doping. However it is very important to recognize
that the doping BIAT does not measure doping, but atti-
tudes to doping. It is possible that there are non-dopers
with relatively positive attitudes to doping just as there
may be dopers with relatively negative attitudes to doping.
In this study there were 16 individuals with positive
D-scores (Figure 3). However IAT effects do not reveal
whether an individual has a positive or negative attitude
to a target in an absolute sense (13). It is inappropriate
to equate a negative D-score with a negative attitude to
doping. One reason for this is that it is not clear what
psychological state corresponds to a zero D-score. Other
reasons are inter-individually different subjective va-
lences of focal and non-focal concepts (of the doping
BIAT) and that the scale for reaction time-based psycho-
logical instruments is generally arbitrary [42]. An individ-
ual (or group mean) IAT D-score can only be interpreted
relative to a comparison group.
Inter-individually different subjective valences of stim-
uli might be another source of bias connected with the
test itself. For example the doping BIAT uses one picture
with syringes to represent the concept of doping, while sy-
ringes themselves might already by negatively associated
through prior personal experiences. Similarly, with regard
to our choice of health food as the second category,
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less positive likewise. According reservations can be ad-
dressed for example in the light of the associative-
propositional evaluation (APE) model [17]. Within this
model the concept of pattern activation refers to the idea
that the relative fit between the pattern of preexisting as-
sociations in memory and the particular set of external in-
put stimuli determines the activation of associations in
memory. In the BIAT participants are instructed to decide
whether presented stimuli either belong to the target cat-
egory (here: doping) or to the attribute ‘like’ (or ‘dislike’ in
the other test block). The second category (here: health
food) throughout the test and the other attribute (‘dislike’)
during the respective test block remain non-focal; partici-
pants are instructed to treat these stimuli as “anything
else”. An associative focus [23], i.e. continuously linking
syringes with doping so that the doping-related association
pattern and not another one remains activated, is even
emphasized as during all sorting trials the focal category
labels remain visible on the screen. Of course this does
not rule out the possibility that even better attitude mea-
surements could be achieved with different picture stimuli
or an alternative non-focal comparison category. Any
given test has unique variance due to its specific test stim-
uli. All the pictorial doping BIAT’s stimuli were carefully
pre-tested [25]. But maybe future studies can try to quan-
tify differences that will most likely result from using alter-
native procedures [20].
42.6% of our bodybuilders’ urine samples contained
doping substances. This prevalence is comparable to that
reported by Delbeke and colleagues almost 20 years ago
[27]. One very important conclusion from this earlier
study was that one substance, the beta agonist clenbu-
terol, appeared in bodybuilders almost one year before it
was first detected in competitive athletes from other
sports. Competitive bodybuilding functions as a testing
ground for innovations in doping (which may later spill
over into Olympic sports). Our findings suggest that the
number of bodybuilders who tend to experiment with
drugs in an irritating irresponsible way is high. Exces-
sively high T/E ratios (in 12 participants in this sample
T/E was > 50), atypically high (>1,000 ng/ml) urinary
concentrations of various steroids (e.g. drostanolone
~5,000 ng/ml) or their metabolites (e.g. 6-hydroxy-
methandieonen ~2,000 ng/mL, 3’-hydroxy-stanozolol ~
2,000 ng/mL) and suppression of the endogenous
precursor of testosterone biosynthesis, luteinizing hor-
mone (LH), are strong indicators of high-dose long-term
abuse of multiple anabolic androgenic steroids. We
found evidence of administration of vastly super-
therapeutic dosages in several participants’ samples, and
use of unapproved experimental drugs may be becoming
more frequent. We detected the designer steroid
methasterone in one urine sample; this drug and severalother substances such as PPARδ receptor agonists,
Growth Hormone Releasing Peptides (GHRPs) and Se-
lective Androgene Receptor Modulators (SARMs), have
been heavily advertised in the bodybuilding literature
lately and are currently easily available from clandestine
sources (and were recurrently confiscated by legality). In
summary, our findings corroborate and extend the find-
ings of case studies [43], administration of somewhat
haphazard combinations of substances, complementary
administration of substances, e.g. anti-oestrogens to treat
side effects (gynecomastia) and use of stimulants to pro-
mote loss of body fat, are the norm rather than the ex-
ception for bodybuilders. Evidence suggesting use of
depot preparations and the fairly high concentrations
found in some samples do not suggest that our partici-
pants intended to avoid testing positive. This scenario
contrasts sharply with that for Olympic sports.
This is the first study to use an indirect psychological
test to assess attitudes to doping in competitive athletes
(bodybuilders) whose doping status was confirmed with
biochemical laboratory tests. It provided clear evidence
– something previously lacking – that clean athletes’ at-
titudes to doping tend to be more negative than those of
doped athletes. A recent review of relevant publications
found only indirect evidence of the association between
attitude to doping and doping behavior [7]. The pictorial
doping BIAT identified almost three out of four doped
athletes. This suggests that similar use of the pictorial
doping BIAT in athletes from Olympic sport would
probably produce a different picture regarding athletes’
doping attitudes than when data is obtained by direct
enquiry in a questionnaire. Most of the extant question-
naire studies report floor effects, with the vast majority
of respondents claiming to reject doping absolutely [44].
Last but not least it is important to note that our study
does not provide evidence for the psychological theory
of implicit cognition, i.e. social cognitive processes that
possess features of automaticity [45]. What it does pro-
vide is evidence that response time latencies on a psy-
chological test, which are thought to reflect learned
associations between mental representations of semantic
concepts (attributes and target concept), can be used to
predict socially sensitive behavior at group level. These
findings demonstrate an association between knowledge
retrieved from our cognitive system and complex real
life behavior (i.e. behavior measured outside artificial re-
search settings). There have been few reports of such as-
sociations so this result is of some importance [46].
Perspectives
This is the first study to provide evidence of the external
validity of an indirect test of athletes’ attitudes to doping.
We suggest that indirect tests of attitude to doping could
be used as part of a portfolio of outcome measures [47,48]
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http://www.substanceabusepolicy.com/content/9/1/36in evaluations of doping prevention programs. In our view
there is an urgent need for robust evaluation of anti-
doping intervention; perhaps because the social desirability
bias makes it difficult to elicit honest expression of atti-
tudes to doping directly from athletes, very few anti-doping
interventions are evaluated at all (e.g. [49]) and none has
used anything other than a questionnaire to assess psycho-
logical effects. As well as demonstrating that it is possible
to predict with reasonable accuracy whether an athlete is a
doper on the basis of a pictorial doping BIAT D-score, this
study can be seen as an attempt to promote the very neces-
sary shift from output-based (e.g. how many anti-doping
interventions were delivered, reaching how many athletes)
to outcome-based evaluations of doping prevention pro-
grams in sport (i.e. what difference did they make, [50]).
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